ReviewNeurology. Clinical practice2023

Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings.

Alette M Wessels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.